Advancing Adherent Cell Assays with SemaCyte® Technology

Adherent cell assays have lagged behind in automation, slowing drug discovery. Semarion’s SemaCyte® microcarrier platform streamlines these workflows by making adherent cells assay-ready, improving scalability and efficiency. CEO Jeroen Verheyen shares the inspiration behind this technology and its impact on high-throughput screening and AI-driven drug discovery. Can you introduce Semarion and explain what inspired the…

Read More

Hillcrest Medical Center displays new advanced technology for treating lung cancer | News

TULSA, Okla. — On Tuesday, Hillcrest Medical Center displayed new advanced technology in a thoracic oncology mobile experience aimed at educating patients on the advancements made in diagnosing and treating lung cancer.  “Hillcrest just got named one of the top six facilities in the United States to become a comprehensive thoracic oncology program,” said Dr. Rachael…

Read More
Back To Top